誘導髓源抑制細胞分化以治療癌症和感染性疾病的方法和組合物

• 收藏
• 分享

专利权人:

OSE IMMUNOTHERAPEUTICS

发明人:

POIRIER, Nicolas,VANHOVE, Bernard

申请号：

HK18102829.3

公开号：

HK1243428A

申请日:

2018.02.27

申请国别(地区):

HK

年份:

2018

代理人:

摘要：

The present invention pertains to the field of immunotherapy. More specifically, the present invention provides a method for differentiating myeloid-derived suppressor cells (MDSC) into non suppressive cells, by administering a compound blocking the interaction between SIRPa and CD47 to a patient in need thereof, in order to reduce MDSC-induced immunodepression and consequently allow appropriate immune responses in cancers, infectious diseases, vaccination, trauma, autoimmune diseases, chronic inflammatory diseases and transplantation.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/